155 related articles for article (PubMed ID: 12124319)
21. Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol.
Guns ES; Goldenberg SL; Brown PN
Can J Urol; 2002 Dec; 9(6):1684-8; discussion 1689. PubMed ID: 12517310
[TBL] [Abstract][Full Text] [Related]
22. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma.
Bonham M; Posakony J; Coleman I; Montgomery B; Simon J; Nelson PS
Clin Cancer Res; 2005 May; 11(10):3905-14. PubMed ID: 15897592
[TBL] [Abstract][Full Text] [Related]
23. Complementary and alternative therapies in prostate cancer.
Oh WK; Small EJ
Semin Oncol; 2002 Dec; 29(6):575-84. PubMed ID: 12516040
[TBL] [Abstract][Full Text] [Related]
24. PC-SPES inhibits cell proliferation by modulating p21, cyclins D, E and B and multiple cell cycle-related genes in prostate cancer cells.
Lu X; Guo J; Hsieh TC
Cell Cycle; 2003; 2(1):59-63. PubMed ID: 12695690
[TBL] [Abstract][Full Text] [Related]
25. In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats.
Wadsworth T; Poonyagariyagorn H; Sullivan E; Koop D; Roselli CE
J Pharmacol Exp Ther; 2003 Jul; 306(1):187-94. PubMed ID: 12676889
[TBL] [Abstract][Full Text] [Related]
26. [PC SPES in prostatic cancer: critical review of the literature].
de la Taille A
Prog Urol; 2001 Jun; 11(3):428-32. PubMed ID: 11512453
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer and the food supplement, PC-SPES. Minireview.
Thomson JO; Dzubak P; Hajduch M
Neoplasma; 2002; 49(2):69-74. PubMed ID: 12088108
[TBL] [Abstract][Full Text] [Related]
28. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
Meyer JP; Gillatt DA
Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
[TBL] [Abstract][Full Text] [Related]
29. PC-SPES: hope or hype?
Kosty MP
J Clin Oncol; 2004 Sep; 22(18):3657-9. PubMed ID: 15289490
[No Abstract] [Full Text] [Related]
30. In vitro mechanism of PC SPES.
Chenn S
Urology; 2001 Aug; 58(2 Suppl 1):28-35; discussion 38. PubMed ID: 11502443
[TBL] [Abstract][Full Text] [Related]
31. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
[TBL] [Abstract][Full Text] [Related]
32. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
33. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth?
Yam J; Kreuter M; Drewe J
Planta Med; 2008 Jan; 74(1):33-8. PubMed ID: 18080233
[TBL] [Abstract][Full Text] [Related]
34. PC-SPES: A cautionary tale.
Harv Mens Health Watch; 2002 Dec; 7(5):8. PubMed ID: 12499133
[No Abstract] [Full Text] [Related]
35. Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract.
Ye F; Jiang S; Volshonok H; Wu J; Zhang DY
Nutr Cancer; 2007; 57(1):100-10. PubMed ID: 17516867
[TBL] [Abstract][Full Text] [Related]
36. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
Meade-Tollin LC; Wijeratne EM; Cooper D; Guild M; Jon E; Fritz A; Zhou GX; Whitesell L; Liang JY; Gunatilaka AA
J Nat Prod; 2004 Jan; 67(1):2-4. PubMed ID: 14738375
[TBL] [Abstract][Full Text] [Related]
37. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
[TBL] [Abstract][Full Text] [Related]
38. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
[TBL] [Abstract][Full Text] [Related]
39. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .
Kubota T; Hisatake J; Hisatake Y; Said JW; Chen SS; Holden S; Taguchi H; Koeffler HP
Prostate; 2000 Feb; 42(3):163-71. PubMed ID: 10639186
[TBL] [Abstract][Full Text] [Related]
40. Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC; Kouros-Mehr H; Kohn KW; Maunakea AK; Lababidi S; Roschke A; Stover K; Alexander J; Pantazis P; Miller L; Liu E; Kirsch IR; Urasaki Y; Pommier Y; Weinstein JN
Cancer Res; 2003 Mar; 63(5):1000-11. PubMed ID: 12615715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]